Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation
Authors:
- Hui-Fen LiaoHLHui-Fen Liao
- Shou-Chuan ShihSSShou-Chuan Shih
- Shee-Chan LinSLShee-Chan Lin
- Wen-Hsiung ChangWCWen-Hsiung Chang
- Cheng-Hsin ChuCCCheng-Hsin Chu
- Tsang-En WangTWTsang-En Wang
- Yu-Jen ChenYCYu-Jen Chen
Open Access
- 1 January 2005
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 11 (27) , 4237-4240
Abstract
Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiationKeywords
This publication has 21 references indexed in Scilit:
- Ganglioside GD3 Sensitizes Human Hepatoma Cells to Cancer TherapyJournal of Biological Chemistry, 2002
- Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2002
- Trends in Survival of Patients With Hepatocellular Carcinoma Between 1977 and 1996 in the United StatesHepatology, 2001
- Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in EuropeEuropean Journal of Cancer, 1998
- Colchicine: 1998 updateSeminars in Arthritis and Rheumatism, 1998
- The Management of GoutNew England Journal of Medicine, 1996
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- DOUBLE-MASKED TRIAL OF CYCLOSPORIN VERSUS COLCHICINE AND LONG-TERM OPEN STUDY OF CYCLOSPORIN IN BEHÇET'S DISEASEThe Lancet, 1989
- Induction of plasma protein secretion in a newly established human hepatoma cell line.Molecular and Cellular Biology, 1983
- Efficacy of Colchicine Prophylaxis in GoutAnnals of Internal Medicine, 1961